Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
View Cart
Checkout
Home
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
“Psychopharmacology Bulletin VOL 36 Supplement No. 2 – Full Issue Stacked PDF” has been added to your cart.
View cart
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
$
0.00
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 4 Articles
Tags:
a-move-toward-evidence
,
editors-note
,
industry
,
michael-e-thase
Description
Description
Editor’s Note: The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry – Michael E. Thase, MD
Related products
Laszlo Gyulai – Correlates of Functioning in Bipolar Disorder
$
30.00
Add to cart
Details
Assessing Rates and Predictors of Tachyphylaxis
$
30.00
Add to cart
Details
Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
